Dr. Yu-Wei Lin is Director of Pharmacometrics at Certara, adjunct Senior Researcher at Monash University, and adjunct Guest Lecturer and Elite Fellow at the University of Malaya. With over a decade of combined academic and industry experience in PK/PD/TD modeling and MIDD, he has partnered with leading pharmaceutical companies to enable regulatory approvals, trial design, and dose optimization across oncology, immunology, pediatrics, and infectious diseases. His work spans small molecules, biologics, ADCs, and siRNA, including a patented pediatric HIV dosing strategy (Patent No. 63/407425). Dr. Lin has published 60+ papers, received NIH and NHMRC funding, and serves as Associate Editor of IJAA, Guest Theme Editor for ADDR, Communication Chair of the ASCPT Oncology Community, and member of several international working groups advancing MIDD standards and education.